Citations in PubMed

Primary Citation PubMed: 22168824 Citations in PubMed

PDB ID Mentions in PubMed Central Article count: 3

Citations in PubMed

This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.

PDB ID Mentions in PubMed Central

Data mentions are occurrences of PDB IDs in the full text articles from the PubMedCentral Open Access Subset of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed. Article titles can be filtered by keywords and sorted by year.

  • 3 per page
  • 5 per page
  • 10 per page
  • view all
  • Publication Year
  • Ascending
  • Descending

Preferential selectivity of inhibitors with human tau protein kinase gsk3? elucidates their potential roles for off-target Alzheimer's therapy.

(2013) Int J Alzheimers Dis 2013

PubMed: 24222885 | PubMedCentral: PMC3810200 | DOI: 10.1155/2013/809386

number Protein name UniProt ID PDB ID Number of residues Ligand present in the PDB structure Nomenclature of inhibitors in the study (1) Glycogen synthase kinase 3 beta (GSK3 β ) P49841 1J1C 4... 0 Adenosine-5′-diphosphate — (2) Cyclin-dependent kinase 5 (CDK5) Q00535 3O0G 292 4-Amino-2-[[4-chlorophenyl]amino]-1,3-thiazol-5-yl][3-nitrophenyl]methanone Inhibitor 1 (3) p38 delta kinase (p38) O15264 3COI 365 No Ligand — (4) Mitogen-activated protein kinase 1 (Erk1/2) P28482 1TVO 360 5-[2-Phenylpyrazolo[1,5-a]pyridin-3-yl]-1h-pyrazolo[3,4-c]pyridazin-3-amine [Drug Bank ID DB07794] Inhibitor 2 (5) Mitogen-activated protein kinase 10 (JNK3) P53779 2O0U 464 N-{3-Cyano-6-[3-[1-piperidinyl]propanoyl]-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl}1-naphthalenecarboxamide Inhibitor 3 (6) Casein kinase 1 delta (CK1d) P48730 3UYT 415 4-[1-Cyclohexyl-4-[4-fluorophenyl]-1H-imidazol-5-yl]pyrimidin-2-amine Inhibitor 4 (7) Dual-specificity tyrosine-[Y]-phosphorylation-regulated kinase 1A (DYRK1A) Q13627 3ANR 763 7-Methoxy-1-methyl-9h-beta-carboline [harmine complex] [Drug Bank ID DB07919] Inhibitor 5 (8) Protein kinase A (PKA) P17612 3MVJ 351 [3R]-1-[5-Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrrolidin-3-amine Inhibitor-6 (3-aminopyrrolidine scaffold) (9) Protein kinase B (PKB/AKT) P31749 3MV5 480 [3R]-1-[5-Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrrolidin-3-amine Inhibitor-6 (3-aminopyrrolidine scaffold) (10) Protein kinase C alpha (PKC) P17252 3IW4 672 3-[1H-Indol-3-yl]-4-[2-[4-methylpiperazin-1-yl]quinazolin-4-yl]-1H-pyrrole-2,5-dione Inhibitor 7 Table 2 Percentage identity, similarity, and RMSD values (for the overlapping number of atoms).

Publication Year: 2013


Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.

(2014) J Med Chem 57

PubMed: 24592867 | PubMedCentral: PMC3969104 | DOI: 10.1021/jm500065f

There are three human CK-1δ crystallographic structures collected in the Protein Data Bank (PDBs entries: 3UYS, 3UYT, 3UZP).

Publication Year: 2014


The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis.

(2014) Front Oncol 4

PubMed: 24904820 | PubMedCentral: PMC4032983 | DOI: 10.3389/fonc.2014.00096

Until today, crystal structures of human CK1 isoforms γ1 (PDB code 2CMW), γ2 (2C47), γ3 (2CHL, 2IZR, 2IZS, 2IZT, 2IZU, 4HGL, 4HGS, 4G16, 4G17), δ (4KB8, 4KBA, 4KBC, 4KB... , 4HNF, 3UYS, 3UYT, 3UZP), and ε (4HNI, 4HOK) are accessible as well.

Publication Year: 2014